Session Chair Profile
President & CEO, Nanostring Technologies
Biography
R. Bradley Gray has served as a member of the Board of Directors and as President and CEO of NanoString since June 2010. Prior to joining our company, Mr. Gray held various positions at Genzyme Genetics, including VP of Product & Business Development, VP of Business & Strategic Development, and Director of Corporate Development. Prior to Genzyme, Mr. Gray was a healthcare management consultant for McKinsey & Company, a global management consulting firm. He received a B.A. in Economics and Management from Oxford University, where he studied as a British Marshall Scholar, and an S.B. in Chemical Engineering from MIT.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis:
As immunotherapies becomes a backbone of cancer treatment, biomarker assays will be critical to optimizing the use of immunotherapies as single agent or in combinations. This panel will explore how leading biopharma and academic researchers are identifying biomarkers and developing companion diagnostics for immuno-oncology.
